APO Research
Talk to an analyst

APO RESEARCH · REPORT

ELISA Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global ELISA Service Market Analysis and Forecast 2026-2032

3 May 2026229 pages

Choose your research edition.

Industry ResearchELISA Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal ELISA Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal ELISA Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ELISA Service Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal ELISA Service Market Analysis and Forecast 2026-2032229 pages · $4,950 USD

Market perspective

The global ELISA Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for ELISA Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for ELISA Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for ELISA Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for ELISA Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of ELISA Service include Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc and R&D Systems, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for ELISA Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of ELISA Service, also provides the revenue of main regions and countries. Of the upcoming market potential for ELISA Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the ELISA Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ELISA Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for ELISA Service revenue, projected growth trends, production technology, application and end-user industry.

ELISA Service Segment by Company

Virology Research Services Ltd

ACROBiosystems

Boster Bio

RayBiotech, Inc

Precision Medicine Group, LLC

Bio-Techne

Cellular Technology Limited（immunospot）

Sino Biological, Inc

R&D Systems, Inc

ProteoGenix

Eve Technologies

NorthEast BioAnalytical Laboratories LLC

mabtech

Pestka Biomedical Laboratories, Inc

Thermo Fisher Scientific

Antibodies Incorporated

Kaneka Eurogentec S.A

ELISA Service Segment by Type

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

ELISA Service Segment by Application

Disease Diagnosis

Vaccine Effectiveness Evaluation

Drug Development

Allergen Testing

Others

ELISA Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISA Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ELISA Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISA Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of ELISA Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of ELISA Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ELISA Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global ELISA Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Direct ELISA Major Player Table 3. Indirect ELISA Major Player Table 4. Sandwich ELISA Major Player Table 5. Competitive ELISA Major Player Table 6. Global ELISA Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Disease Diagnosis Major Player Table 8. Vaccine Effectiveness Evaluation Major Player Table 9. Drug Development Major Player Table 10. Allergen Testing Major Player Table 11. Others Major Player Table 12. ELISA Service Industry Trends Table 13. ELISA Service Industry Drivers Table 14. ELISA Service Industry Opportunities and Challenges Table 15. ELISA Service Industry Restraints Table 16. Global ELISA Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global ELISA Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global ELISA Service Market Share by Region (2021-2026) Table 19. Global ELISA Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global ELISA Service Market Share by Region (2027-2032) Table 21. Global ELISA Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global ELISA Service Revenue Market Share by Players (2021-2026) Table 23. Global ELISA Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global ELISA Service Key Players Headquarters & Area Served Table 25. Global ELISA Service Players, Product Type & Application Table 26. Global ELISA Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global ELISA Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global ELISA Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global ELISA Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global ELISA Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global ELISA Service Revenue Market Share by Type (2021-2026) Table 33. Global ELISA Service Revenue Market Share by Type (2027-2032) Table 34. Global ELISA Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global ELISA Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global ELISA Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global ELISA Service Revenue Market Share by Application (2021-2026) Table 38. Global ELISA Service Revenue Market Share by Application (2027-2032) Table 39. Virology Research Services Ltd Company Information Table 40. Virology Research Services Ltd Business Overview Table 41. Virology Research Services Ltd ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Virology Research Services Ltd ELISA Service Product Portfolio Table 43. Virology Research Services Ltd Recent Development Table 44. ACROBiosystems Company Information Table 45. ACROBiosystems Business Overview Table 46. ACROBiosystems ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. ACROBiosystems ELISA Service Product Portfolio Table 48. ACROBiosystems Recent Development Table 49. Boster Bio Company Information Table 50. Boster Bio Business Overview Table 51. Boster Bio ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Boster Bio ELISA Service Product Portfolio Table 53. Boster Bio Recent Development Table 54. RayBiotech, Inc Company Information Table 55. RayBiotech, Inc Business Overview Table 56. RayBiotech, Inc ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. RayBiotech, Inc ELISA Service Product Portfolio Table 58. RayBiotech, Inc Recent Development Table 59. Precision Medicine Group, LLC Company Information Table 60. Precision Medicine Group, LLC Business Overview Table 61. Precision Medicine Group, LLC ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Precision Medicine Group, LLC ELISA Service Product Portfolio Table 63. Precision Medicine Group, LLC Recent Development Table 64. Bio-Techne Company Information Table 65. Bio-Techne Business Overview Table 66. Bio-Techne ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Bio-Techne ELISA Service Product Portfolio Table 68. Bio-Techne Recent Development Table 69. Cellular Technology Limited（immunospot） Company Information Table 70. Cellular Technology Limited（immunospot） Business Overview Table 71. Cellular Technology Limited（immunospot） ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Cellular Technology Limited（immunospot） ELISA Service Product Portfolio Table 73. Cellular Technology Limited（immunospot） Recent Development Table 74. Sino Biological, Inc Company Information Table 75. Sino Biological, Inc Business Overview Table 76. Sino Biological, Inc ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Sino Biological, Inc ELISA Service Product Portfolio Table 78. Sino Biological, Inc Recent Development Table 79. R&D Systems, Inc Company Information Table 80. R&D Systems, Inc Business Overview Table 81. R&D Systems, Inc ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. R&D Systems, Inc ELISA Service Product Portfolio Table 83. R&D Systems, Inc Recent Development Table 84. ProteoGenix Company Information Table 85. ProteoGenix Business Overview Table 86. ProteoGenix ELISA Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. ProteoGenix ELISA Service Product Portfolio Table 88. ProteoGenix Recent Development Table 89. Eve Technologies Company Information Table 90. Eve Technologies Business Overview Table 91. Eve Technologies ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Eve Technologies ELISA Service Product Portfolio Table 93. Eve Technologies Recent Development Table 94. NorthEast BioAnalytical Laboratories LLC Company Information Table 95. NorthEast BioAnalytical Laboratories LLC Business Overview Table 96. NorthEast BioAnalytical Laboratories LLC ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. NorthEast BioAnalytical Laboratories LLC ELISA Service Product Portfolio Table 98. NorthEast BioAnalytical Laboratories LLC Recent Development Table 99. mabtech Company Information Table 100. mabtech Business Overview Table 101. mabtech ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. mabtech ELISA Service Product Portfolio Table 103. mabtech Recent Development Table 104. Pestka Biomedical Laboratories, Inc Company Information Table 105. Pestka Biomedical Laboratories, Inc Business Overview Table 106. Pestka Biomedical Laboratories, Inc ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Pestka Biomedical Laboratories, Inc ELISA Service Product Portfolio Table 108. Pestka Biomedical Laboratories, Inc Recent Development Table 109. Thermo Fisher Scientific Company Information Table 110. Thermo Fisher Scientific Business Overview Table 111. Thermo Fisher Scientific ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Thermo Fisher Scientific ELISA Service Product Portfolio Table 113. Thermo Fisher Scientific Recent Development Table 114. Antibodies Incorporated Company Information Table 115. Antibodies Incorporated Business Overview Table 116. Antibodies Incorporated ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Antibodies Incorporated ELISA Service Product Portfolio Table 118. Antibodies Incorporated Recent Development Table 119. Kaneka Eurogentec S.A Company Information Table 120. Kaneka Eurogentec S.A Business Overview Table 121. Kaneka Eurogentec S.A ELISA Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Kaneka Eurogentec S.A ELISA Service Product Portfolio Table 123. Kaneka Eurogentec S.A Recent Development Table 124. North America ELISA Service Revenue by Type (2021-2026) & (US$ Million) Table 125. North America ELISA Service Revenue by Type (2027-2032) & (US$ Million) Table 126. North America ELISA Service Revenue by Application (2021-2026) & (US$ Million) Table 127. North America ELISA Service Revenue by Application (2027-2032) & (US$ Million) Table 128. North America ELISA Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America ELISA Service Revenue by Country (2021-2026) & (US$ Million) Table 130. North America ELISA Service Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe ELISA Service Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe ELISA Service Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe ELISA Service Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe ELISA Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe ELISA Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe ELISA Service Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe ELISA Service Revenue by Country (US$ Million) & (2027-2032) Table 138. China ELISA Service Revenue by Type (2021-2026) & (US$ Million) Table 139. China ELISA Service Revenue by Type (2027-2032) & (US$ Million) Table 140. China ELISA Service Revenue by Application (2021-2026) & (US$ Million) Table 141. China ELISA Service Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia ELISA Service Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia ELISA Service Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia ELISA Service Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia ELISA Service Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia ELISA Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia ELISA Service Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia ELISA Service Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA ELISA Service Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA ELISA Service Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA ELISA Service Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA ELISA Service Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA ELISA Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA ELISA Service Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA ELISA Service Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. ELISA Service Image Figure 2. Global ELISA Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ELISA Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Direct ELISA Image Figure 5. Indirect ELISA Image Figure 6. Sandwich ELISA Image Figure 7. Competitive ELISA Image Figure 8. Global ELISA Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global ELISA Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Disease Diagnosis Image Figure 11. Vaccine Effectiveness Evaluation Image Figure 12. Drug Development Image Figure 13. Allergen Testing Image Figure 14. Others Image Figure 15. Global ELISA Service Market Size (US$ Million) & (2021-2032) Figure 16. Global ELISA Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global ELISA Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global ELISA Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global ELISA Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global ELISA Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global ELISA Service Revenue Market Share by Type (2021-2032) Figure 23. Global ELISA Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global ELISA Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global ELISA Service Revenue Market Share by Application (2021-2032) Figure 26. North America ELISA Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America ELISA Service Revenue Share by Type (2021-2032) Figure 28. North America ELISA Service Revenue Share by Application (2021-2032) Figure 29. North America ELISA Service Revenue Share by Country (2021-2032) Figure 30. United States ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe ELISA Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe ELISA Service Revenue Share by Type (2021-2032) Figure 35. Europe ELISA Service Revenue Share by Application (2021-2032) Figure 36. Europe ELISA Service Revenue Share by Country (2021-2032) Figure 37. Germany ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China ELISA Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China ELISA Service Revenue Share by Type (2021-2032) Figure 47. China ELISA Service Revenue Share by Application (2021-2032) Figure 48. Asia ELISA Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia ELISA Service Revenue Share by Type (2021-2032) Figure 50. Asia ELISA Service Revenue Share by Application (2021-2032) Figure 51. Asia ELISA Service Revenue Share by Region (2021-2032) Figure 52. Japan ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA ELISA Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA ELISA Service Revenue Share by Type (2021-2032) Figure 60. SAMEA ELISA Service Revenue Share by Application (2021-2032) Figure 61. SAMEA ELISA Service Revenue Share by Country (2021-2032) Figure 62. Brazil ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt ELISA Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA
Applications
  • Disease Diagnosis
  • Vaccine Effectiveness Evaluation
  • Drug Development
  • Allergen Testing
  • Others
Companies covered
  • Virology Research Services Ltd
  • ACROBiosystems
  • Boster Bio
  • RayBiotech, Inc
  • Precision Medicine Group, LLC
  • Bio-Techne
  • Cellular Technology Limited（immunospot）
  • Sino Biological, Inc
  • R&D Systems, Inc
  • ProteoGenix
  • Eve Technologies
  • NorthEast BioAnalytical Laboratories LLC
  • mabtech
  • Pestka Biomedical Laboratories, Inc
  • Thermo Fisher Scientific
  • Antibodies Incorporated
  • Kaneka Eurogentec S.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 ELISA Service Market by Type
  3. 1.2.1 Global ELISA Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Direct ELISA
  5. 1.2.3 Indirect ELISA
  6. 1.2.4 Sandwich ELISA
  7. 1.2.5 Competitive ELISA
  8. 1.3 ELISA Service Market by Application
  9. 1.3.1 Global ELISA Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Disease Diagnosis
  11. 1.3.3 Vaccine Effectiveness Evaluation
  12. 1.3.4 Drug Development
  13. 1.3.5 Allergen Testing
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 ELISA Service Market Dynamics
  1. 2.1 ELISA Service Industry Trends
  2. 2.2 ELISA Service Industry Drivers
  3. 2.3 ELISA Service Industry Opportunities and Challenges
  4. 2.4 ELISA Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global ELISA Service Market Perspective (2021-2032)
  2. 3.2 Global ELISA Service Growth Trends by Region
  3. 3.2.1 Global ELISA Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global ELISA Service Market Size by Region (2021-2026)
  5. 3.2.3 Global ELISA Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global ELISA Service Revenue by Players
  2. 4.1.1 Global ELISA Service Revenue by Players (2021-2026)
  3. 4.1.2 Global ELISA Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global ELISA Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global ELISA Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global ELISA Service Key Players Headquarters & Area Served
  7. 4.4 Global ELISA Service Players, Product Type & Application
  8. 4.5 Global ELISA Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global ELISA Service Market CR5 and HHI
  11. 4.6.3 2025 ELISA Service Tier 1, Tier 2, and Tier 3
5 ELISA Service Market Size by Type
  1. 5.1 Global ELISA Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global ELISA Service Revenue by Type (2021-2032)
  3. 5.3 Global ELISA Service Revenue Market Share by Type (2021-2032)
6 ELISA Service Market Size by Application
  1. 6.1 Global ELISA Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global ELISA Service Revenue by Application (2021-2032)
  3. 6.3 Global ELISA Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Virology Research Services Ltd
  2. 7.1.1 Virology Research Services Ltd Company Information
  3. 7.1.2 Virology Research Services Ltd Business Overview
  4. 7.1.3 Virology Research Services Ltd ELISA Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Virology Research Services Ltd ELISA Service Product Portfolio
  6. 7.1.5 Virology Research Services Ltd Recent Developments
  7. 7.2 ACROBiosystems
  8. 7.2.1 ACROBiosystems Company Information
  9. 7.2.2 ACROBiosystems Business Overview
  10. 7.2.3 ACROBiosystems ELISA Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ACROBiosystems ELISA Service Product Portfolio
  12. 7.2.5 ACROBiosystems Recent Developments
  13. 7.3 Boster Bio
  14. 7.3.1 Boster Bio Company Information
  15. 7.3.2 Boster Bio Business Overview
  16. 7.3.3 Boster Bio ELISA Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Boster Bio ELISA Service Product Portfolio
  18. 7.3.5 Boster Bio Recent Developments
  19. 7.4 RayBiotech, Inc
  20. 7.4.1 RayBiotech, Inc Company Information
  21. 7.4.2 RayBiotech, Inc Business Overview
  22. 7.4.3 RayBiotech, Inc ELISA Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 RayBiotech, Inc ELISA Service Product Portfolio
  24. 7.4.5 RayBiotech, Inc Recent Developments
  25. 7.5 Precision Medicine Group, LLC
  26. 7.5.1 Precision Medicine Group, LLC Company Information
  27. 7.5.2 Precision Medicine Group, LLC Business Overview
  28. 7.5.3 Precision Medicine Group, LLC ELISA Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Precision Medicine Group, LLC ELISA Service Product Portfolio
  30. 7.5.5 Precision Medicine Group, LLC Recent Developments
  31. 7.6 Bio-Techne
  32. 7.6.1 Bio-Techne Company Information
  33. 7.6.2 Bio-Techne Business Overview
  34. 7.6.3 Bio-Techne ELISA Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Techne ELISA Service Product Portfolio
  36. 7.6.5 Bio-Techne Recent Developments
  37. 7.7 Cellular Technology Limited（immunospot）
  38. 7.7.1 Cellular Technology Limited（immunospot） Company Information
  39. 7.7.2 Cellular Technology Limited（immunospot） Business Overview
  40. 7.7.3 Cellular Technology Limited（immunospot） ELISA Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cellular Technology Limited（immunospot） ELISA Service Product Portfolio
  42. 7.7.5 Cellular Technology Limited（immunospot） Recent Developments
  43. 7.8 Sino Biological, Inc
  44. 7.8.1 Sino Biological, Inc Company Information
  45. 7.8.2 Sino Biological, Inc Business Overview
  46. 7.8.3 Sino Biological, Inc ELISA Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sino Biological, Inc ELISA Service Product Portfolio
  48. 7.8.5 Sino Biological, Inc Recent Developments
  49. 7.9 R&D Systems, Inc
  50. 7.9.1 R&D Systems, Inc Company Information
  51. 7.9.2 R&D Systems, Inc Business Overview
  52. 7.9.3 R&D Systems, Inc ELISA Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 R&D Systems, Inc ELISA Service Product Portfolio
  54. 7.9.5 R&D Systems, Inc Recent Developments
  55. 7.10 ProteoGenix
  56. 7.10.1 ProteoGenix Company Information
  57. 7.10.2 ProteoGenix Business Overview
  58. 7.10.3 ProteoGenix ELISA Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ProteoGenix ELISA Service Product Portfolio
  60. 7.10.5 ProteoGenix Recent Developments
  61. 7.11 Eve Technologies
  62. 7.11.1 Eve Technologies Company Information
  63. 7.11.2 Eve Technologies Business Overview
  64. 7.11.3 Eve Technologies ELISA Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Eve Technologies ELISA Service Product Portfolio
  66. 7.11.5 Eve Technologies Recent Developments
  67. 7.12 NorthEast BioAnalytical Laboratories LLC
  68. 7.12.1 NorthEast BioAnalytical Laboratories LLC Company Information
  69. 7.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview
  70. 7.12.3 NorthEast BioAnalytical Laboratories LLC ELISA Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 NorthEast BioAnalytical Laboratories LLC ELISA Service Product Portfolio
  72. 7.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
  73. 7.13 mabtech
  74. 7.13.1 mabtech Company Information
  75. 7.13.2 mabtech Business Overview
  76. 7.13.3 mabtech ELISA Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 mabtech ELISA Service Product Portfolio
  78. 7.13.5 mabtech Recent Developments
  79. 7.14 Pestka Biomedical Laboratories, Inc
  80. 7.14.1 Pestka Biomedical Laboratories, Inc Company Information
  81. 7.14.2 Pestka Biomedical Laboratories, Inc Business Overview
  82. 7.14.3 Pestka Biomedical Laboratories, Inc ELISA Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Pestka Biomedical Laboratories, Inc ELISA Service Product Portfolio
  84. 7.14.5 Pestka Biomedical Laboratories, Inc Recent Developments
  85. 7.15 Thermo Fisher Scientific
  86. 7.15.1 Thermo Fisher Scientific Company Information
  87. 7.15.2 Thermo Fisher Scientific Business Overview
  88. 7.15.3 Thermo Fisher Scientific ELISA Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Thermo Fisher Scientific ELISA Service Product Portfolio
  90. 7.15.5 Thermo Fisher Scientific Recent Developments
  91. 7.16 Antibodies Incorporated
  92. 7.16.1 Antibodies Incorporated Company Information
  93. 7.16.2 Antibodies Incorporated Business Overview
  94. 7.16.3 Antibodies Incorporated ELISA Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Antibodies Incorporated ELISA Service Product Portfolio
  96. 7.16.5 Antibodies Incorporated Recent Developments
  97. 7.17 Kaneka Eurogentec S.A
  98. 7.17.1 Kaneka Eurogentec S.A Company Information
  99. 7.17.2 Kaneka Eurogentec S.A Business Overview
  100. 7.17.3 Kaneka Eurogentec S.A ELISA Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Kaneka Eurogentec S.A ELISA Service Product Portfolio
  102. 7.17.5 Kaneka Eurogentec S.A Recent Developments
8 North America
  1. 8.1 North America ELISA Service Revenue (2021-2032)
  2. 8.2 North America ELISA Service Revenue by Type (2021-2032)
  3. 8.2.1 North America ELISA Service Revenue by Type (2021-2026)
  4. 8.2.2 North America ELISA Service Revenue by Type (2027-2032)
  5. 8.3 North America ELISA Service Revenue Share by Type (2021-2032)
  6. 8.4 North America ELISA Service Revenue by Application (2021-2032)
  7. 8.4.1 North America ELISA Service Revenue by Application (2021-2026)
  8. 8.4.2 North America ELISA Service Revenue by Application (2027-2032)
  9. 8.5 North America ELISA Service Revenue Share by Application (2021-2032)
  10. 8.6 North America ELISA Service Revenue by Country
  11. 8.6.1 North America ELISA Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America ELISA Service Revenue by Country (2021-2026)
  13. 8.6.3 North America ELISA Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe ELISA Service Revenue (2021-2032)
  2. 9.2 Europe ELISA Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe ELISA Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe ELISA Service Revenue by Type (2027-2032)
  5. 9.3 Europe ELISA Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe ELISA Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe ELISA Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe ELISA Service Revenue by Application (2027-2032)
  9. 9.5 Europe ELISA Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe ELISA Service Revenue by Country
  11. 9.6.1 Europe ELISA Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe ELISA Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe ELISA Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China ELISA Service Revenue (2021-2032)
  2. 10.2 China ELISA Service Revenue by Type (2021-2032)
  3. 10.2.1 China ELISA Service Revenue by Type (2021-2026)
  4. 10.2.2 China ELISA Service Revenue by Type (2027-2032)
  5. 10.3 China ELISA Service Revenue Share by Type (2021-2032)
  6. 10.4 China ELISA Service Revenue by Application (2021-2032)
  7. 10.4.1 China ELISA Service Revenue by Application (2021-2026)
  8. 10.4.2 China ELISA Service Revenue by Application (2027-2032)
  9. 10.5 China ELISA Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia ELISA Service Revenue (2021-2032)
  2. 11.2 Asia ELISA Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia ELISA Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia ELISA Service Revenue by Type (2027-2032)
  5. 11.3 Asia ELISA Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia ELISA Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia ELISA Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia ELISA Service Revenue by Application (2027-2032)
  9. 11.5 Asia ELISA Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia ELISA Service Revenue by Country
  11. 11.6.1 Asia ELISA Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia ELISA Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia ELISA Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA ELISA Service Revenue (2021-2032)
  2. 12.2 SAMEA ELISA Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA ELISA Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA ELISA Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA ELISA Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA ELISA Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA ELISA Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA ELISA Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA ELISA Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA ELISA Service Revenue by Country
  11. 12.6.1 SAMEA ELISA Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA ELISA Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA ELISA Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst